GTF2I and thymoma: Paradoxically, TFII-I is noted to be an oncogene and a gain of function mutation is involved in thymomas and exhibits pro-proliferative capabilities in in vitro experiments (14), although proliferative potentials of TFII-I in B cells have never been tested before.